The immune system must maintain a delicate balance to defend against harmful threats while avoiding excessive inflammation. When this balance is disrupted, immune responses can contribute to autoimmune diseases and cancer. A research team jointly led b…
How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center for Individualized Infection Medicine (CiiM), which is a joint institution of the Helmholtz Center for Infection Research (HZI)…
Researchers and doctors are beginning to modernize asthma treatment using innovative therapies.
While early allergen introduction may reduce long-term allergy risk, it is tied to an increase in emergency department (ED) visits for food reactions in infancy, according to a study published in the March issue of the Journal of Allergy and Clinical I…
A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help people with generalized myasthenia gravis, a disease where the body accidentally attacks the cells that help your nerves and musc…
New research reveals how Parkinson’s spreads from the gut to the brain, with the help of immune cells—offering a new potential therapeutic strategy—in a study in mice led by scientists at the UK Dementia Research Institute at UCL (University College Lo…
Baylor College of Medicine researchers are part of a collaborative research group with AstraZeneca and Memorial Sloan Kettering Cancer Center that have identified 22 genes which increase the risk of developing a range of chronic conditions following a …
When our body fights an infection, the immune system must quickly activate defenses and trigger a beneficial inflammatory response. But it is just as important to resolve that inflammation and return to homeostasis. Macrophages play a key role in this …
UVA Health scientists have developed a promising new way to create vaccines that could be faster, cheaper, and easier to distribute than current options. The University of Virginia School of Medicine’s Dr. Steven L. Zeichner leads the team that is refi…
Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why some cancer patients benefit from immunotherapy while others do not.
